Latest Placebo-controlled study Stories
There has always been a large focus on testing new treatments for cancer and disease, but a new study on Idiopathic pulmonary fibrosis (IPF) sheds light on the importance of testing standard treatment, as it could present fatal risks as well.
A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis.
Scientific proof for the effectiveness of Zymaderm™ in the treatment of molluscum contagiosum was announced today by Naturopathix,Inc., with the publication of a randomized controlled clinical
- The parings of haberdine; also, any kind of fragments.